Targeting STING oligomerization with small-molecule inhibitors

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Stimulator of interferon genes (STING) is an essential adaptor protein required for the inflammatory response to cytosolic DNA. dsDNA activates cGAS to generate cGAMP, which binds and activates STING triggering a conformational change, oligomerization, and the IRF3- and NFκB-dependent transcription of type I Interferons (IFNs) and inflammatory cytokines, as well as the activation of autophagy. Aberrant activation of STING is now linked to a growing number of both rare as well as common chronic inflammatory diseases. Here, we identify and characterize a potent small-molecule inhibitor of STING. This compound, BB-Cl-amidine inhibits STING signaling and production of type I IFNs, IFN-stimulated genes (ISGs) and NFκB-dependent cytokines, but not other pattern recognition receptors. In vivo, BB-Cl-amidine alleviated pathology resulting from accrual of cytosolic DNA in Trex-1 mutant mice. Mechanistically BB-Cl-amidine inhibited STING oligomerization through modification of Cys 148 . Collectively, our work uncovers an approach to inhibit STING activation and highlights the potential of this strategy for the treatment of STING-driven inflammatory diseases.
Funding Information
  • Li Weibo Institute for Rare Diseases (N/A)
  • UMass Chan OTCV Technology Fund (N/A)
  • UMass Chan Bridge Fund (N/A)
  • HHS|NIH|National Institute of General Medical Sciences (T32 GM107000)
  • HHS|NIH|National Institute of Allergy and Infectious Diseases (T32 AI132152)

This publication has 39 references indexed in Scilit: